1,232 results on '"Gale, Chris P"'
Search Results
202. European Society of Cardiology quality indicators for the care and outcomes of adults with heart failure. Developed by the Working Group for Heart Failure Quality Indicators in collaboration with the Heart Failure Association of the European Society of Cardiology
203. Risks and Benefits of Oral Anticoagulants for Stroke Prophylaxis in Atrial Fibrillation According to Body Mass Index: Nationwide Cohort Study of Primary Care Records in England
204. What is next for screening for undiagnosed atrial fibrillation? Artificial intelligence may hold the key
205. Addressing disparities of care in non-ST-segment elevation myocardial infarction patients without standard modifiable risk factors: insights from a nationwide cohort study
206. Collateral cardiovascular damage during the COVID-19 pandemic
207. Statins for primary prevention among elderly men and women
208. Using electronic health records to predict costs and outcomes in stable coronary artery disease
209. Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure
210. Assessment of palpitations
211. European Society of Cardiology quality indicators for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed in collaboration with the European Heart Rhythm Association of the European Society of Cardiology
212. Pro
213. 2020 ESC Guidelines on the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndrome Working Group of the European Society of Cardiology (ESC) for the diagnosis and treatment of acute coronary syndrome (ACS) in patients without persistent ST segment elevation
214. Analysis of a Web-Based Dashboard to Support the Use of National Audit Data in Quality Improvement: Realist Evaluation
215. Abstract 12334: Concerns About the Use of Digoxin in Acute Coronary Syndromes
216. Abstract 12363: Statin Use and Severity of First Manifestation of Coronary Heart Disease Across Age and Sex
217. Aortic stenosis post-COVID-19: A mathematical model on waiting lists and mortality
218. European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology
219. Prediction of incident atrial fibrillation in community-based electronic health records: a systematic review with meta-analysis
220. Association of hospital performance measures with readmissions for patients with heart failure: A report from JROAD-DPC study
221. Epidemiology of cardiovascular disease in Europe
222. Impact of the admitting ward on care quality and outcomes in non-ST-segment elevation myocardial infarction: insights from a national registry
223. Multimorbidity and survival for patients with acute myocardial infarction in England and Wales: Latent class analysis of a nationwide population-based cohort
224. The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes
225. Methodology for the development of international clinical data standards for common cardiovascular conditions: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)
226. Second Decline in Admissions With Heart Failure and Myocardial Infarction During the COVID-19 Pandemic
227. Comparison of hospital variation in acute myocardial infarction care and outcome between Sweden and United Kingdom: population based cohort study using nationwide clinical registries
228. Acute myocardial infarction and inter-hospital transfer
229. Profile and treatment of chronic coronary syndromes in European Society of Cardiology member countries: The ESC EORP CICD-LT registry
230. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
231. Quality indicators for the care and outcomes of adults with atrial fibrillation
232. Quality indicators for the care and outcomes of adults with atrial fibrillation:Task Force for the development of quality indicators in atrial fibrillation of the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC): Developed in collaboration with the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS)
233. Outcomes of conduction system pacing compared to right ventricular pacing as a primary strategy for treating bradyarrhythmia: systematic review and meta-analysis.
234. collateral damage of COVID-19 to cardiovascular services: a meta-analysis.
235. Contemporary roles of registries in clinical cardiology: when do we need randomized trials?
236. European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing: developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European Heart Rhythm Association of the European Society of Cardiology
237. Japanese Cardiovascular Disease Registry Research Is Heading for a New Era ― Significance of Disease Registries in the Era of Real-World Data ―
238. 03 The prehospital 12 lead electrocardiogram is associated with improved outcomes in patients with acute coronary syndromes presenting to emergency medical services: a nationwide linked cohort study
239. Outcomes of conduction system pacing compared to right ventricular pacing as a primary strategy for treating bradyarrhythmia: systematic review and meta-analysis
240. Methodology for the development of international clinical data standards for common cardiovascular conditions: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)
241. Excess deaths from COVID-19 and other causes by region, neighbourhood deprivation level and place of death during the first 30 weeks of the pandemic in England and Wales: A retrospective registry study
242. Development and Validation of a Multivariable Risk Prediction Model for Sudden Cardiac Death after Myocardial Infarction (PROFID Risk Model): Study Rationale, Design and Protocol
243. Hidden labour: the skilful work of clinical audit data collection and its implications for secondary use of data via integrated health IT
244. Concerns about the use of digoxin in acute coronary syndromes
245. Excess years of life lost to COVID-19 and other causes of death by sex, neighbourhood deprivation and region in England & Wales during 2020
246. Quality of acute myocardial infarction care in England and Wales during the COVID-19 pandemic: linked nationwide cohort study
247. Guía ESC 2020 sobre el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST
248. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
249. Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study
250. 2020 Update of the quality indicators for acute myocardial infarction : a position paper of the Association for Acute Cardiovascular Care : the study group for quality indicators from the ACVC and the NSTE-ACS guideline group
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.